Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625426 | SCV000745334 | benign | Lipase deficiency, combined | 2017-11-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000883435 | SCV001026743 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000883435 | SCV001790367 | likely benign | not provided | 2020-08-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002385961 | SCV002692833 | benign | Cardiovascular phenotype | 2019-08-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000883435 | SCV005216378 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001701417 | SCV001922078 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003917990 | SCV004745155 | benign | LMF1-related disorder | 2019-03-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |